National
Gay diplomat presses LGBT issues at int’l conference
Guest focuses on hate crimes, Pride celebrations in remarks
Michael Guest, former U.S. ambassador to Romania, headed a delegation during the human rights portion of an annual conference for the Organization for Security & Cooperation in Europe. (Blade photo by Michael Key)
A gay diplomat led a U.S. delegation at an international conference earlier this month that touched on the importance of LGBT rights as a human rights issue.
Michael Guest, former U.S. ambassador to Romania, headed a delegation of about 25 U.S. diplomats during the human rights portion of an annual review conference for the Organization for Security & Cooperation in Europe. The review conference took place between Sept. 30 and Oct. 8 in Warsaw, Poland.
The Warsaw Review Conference was a primer engagement for trans-Atlantic countries to discuss human rights principles — including hate crimes against LGBT people and the freedom to association to have Pride celebrations across the globe — in anticipation of a later OSCE summit that this year is set to take place in December in Astana, Kazakhstan.
In an interview with the Washington Blade, Guest said that his sexual orientation made his designation as head of the delegation representational of the Obama administration’s stated principle that international LGBT rights are human rights.
“I also think that it made an impact with other delegations,” Guest added. “It was clearly a prominent feature of my biography, so there were a number of delegation members that come and it’s representative in their eyes as a sense of progress that an openly gay man would be appointed.”
Still, Guest said he thinks his 26-year service as a diplomat was the primary reason he was selected for the position and noted that during much of his career he focused on OSCE policy.
“I dealt with it at the time when all these changes were happening in Europe in 1989, 1990 and 1991 and when most of the commitments on fundamental freedoms and human rights were signed by the newly independent countries of the former Soviet Union and the new democracies of Central and Eastern Europe,” he said.
Guest attained notoriety in 2007 when he retired from the State Department in protest because it didn’t offer certain benefits — such as security training and free medical care — to the same-sex partners of Foreign Service officers. The situation has since been rectified by Secretary of State Hillary Clinton.
Mark Bromley, chair of the Council for Global Equality, which took part in the review conference as an non-governmental organization, said the selection of an out gay man to lead the U.S. delegation was significant because previous administrations have been reluctant to incorporate LGBT issues in foreign policy.
“The United States in the past has been reluctant to address LGBT concerns within this forum,” Bromley said. “I think the fact that they selected Michael Guest as someone who is openly gay and works with organizations that promote issues on the basis of sexual orientation and gender identity was an important statement.”
The OSCE was established in 1975 after 35 trans-Atlantic countries, including the United States and the Soviet Union, signed the Helsinki Accords and agreed to take part in annual meetings. During the Cold War, the OSCE served as a forum where the United States could raise human rights and security issues with Warsaw Pact countries.
But Guest said the tone of the conference has changed since the collapse of the Soviet Union in 1991 to become less of an East-West dialogue and more of a pan-Atlantic conversation.
“It’s an opportunity to look at what has been done and is being done on human rights issues ranging from migration to freedoms of assembly and freedom of religion, to human trafficking, to capital punishment, to gender balance to hate crimes and intolerance — the whole range of human rights related issues,” Guest said.
During the course of the discussion on human rights, Guest impressed upon the 56 participating states in the conference the importance of inclusion of LGBT rights as human rights issues.
The former ambassador mentioned LGBT issues during his opening statement at the conference’s plenary session, including bias-motivated violence against LGBT people and the right to freedom of association at Pride celebrations. Such activities in Eastern Europe, where the conference took place, are often the targets of hostility and violence.
Guest lamented human rights abuses such as “when civil society assemblies are denied permits on spurious grounds, or police allow bigots to attack Gay Pride parades.” The former ambassador also acknowledged the United States has more to accomplish on human rights issues because “equality under the law continues to elude those of us who are gay or transgender.”
During a later discussion, Guest also appealed to governments in attendance to implement hate crimes protections measures and recalled his own personal experience as the victim of bias-motivated violence.
After a hostile non-governmental organization equated homosexuality to pedophilia and necrophilia at the end of the meeting, Guest responded that the connection was offensive and such inflammatory allegations can be responsible for hate crimes.
Guest told the Blade he raised LGBT issues during the conference because he believes they should be brought up in any comprehensive discussion of human rights.
“We raised it in questions of freedom to assembly, freedom of association and in the course of the discussions on hate crimes and tolerance,” he said. “We had some good news stories to tell from the standpoint of the United States, such as the passage of the Matthew Shepard Act and the overall trend in hate crimes going down, but the negative, of course, being that the reported number of LGBT hate crimes and hate crimes against immigrants has, in fact, gone up.”
LGBT issues were also raised by non-governmental institutions at the conference, including the Council for Global Equality.
Bromley delivered a statement at the conference on behalf of his organization — as well as two European international LGBT right groups — that called for passage of hate crimes protections in other countries as well as the decriminalization of sodomy.
Emphasizing the importance of accurate documentation and effective prosecution of bias-motivated violence against LGBT people, Bromley said hate crimes won’t go away as long as countries have anti-gay statutes on the books.
“As a first step, we call on all participating states in the OSCE region to remove any laws that continue to criminalize homosexual conduct or identity or the public dissemination of scientifically supported information on homosexuality and sexual health,” Bromley said.
Bromley told the Blade that discussion of LGBT rights at the conference was significant because the U.S. delegation had only begun to bring up such issues last year after the start of the Obama administration.
“We’re very pleased to see that level of emphasis from the head of the delegation, but a number of other governments also spoke to the issue, so it’s certainly gaining ground and giving additional attention to LGBT hate crimes,” Bromley said.
The delegations from other countries and other non-governmental organizations at the conference responded to the U.S. delegation’s promotion of LGBT rights in varied ways. Guest said the session in which he spoke personally about hate crimes issues caused delegations from other countries to take note.
“It was a very quiet session,” Guest said. “People were listening very quietly, and a lot of people did respond specifically to what I said including non-governmental organizations. A number of delegations told us afterwards — either to me directly or others on the team — how that more personal approach really had resonated with them.”
Guest said a representative from the Catholic Church in Vatican City was among those that approached him afterward and mentioned that talking about hate crimes in a personal manner was “a way that we could build bridges.”
But Guest said the outcome was different for discussions of freedom of association and the right to hold Pride celebrations. The former ambassador speculated these talks made less of an impact on the delegation because they had already come up at last year’s conference.
“I think it’s just that because Gay Pride issues have come up before, there were some delegations that maybe expected it and maybe didn’t really reflect as much as might otherwise be the case,” Guest said.
So-called “ex-gay” groups and other organizations hostile to LGBT rights were also present.
Bromley said Redeemed Lives, a Christian ministry, spoke out at the conference about bias-motivated violence against “ex-gay” people for giving up what the ministry called a “homosexual lifestyle.”
“That was somewhat alarming to see a strong showing of ex-gay activists who were waving issues that were, as far as I know, not legitimate concerns,” Bromley said. “I don’t doubt that there could be violence directed at ex-gay individuals, but I never heard of any reports to that effect.”
Reparative therapy programs that seek to change sexual orientation have been widely discredited by major medical and psychiatric associations around the world.
A spokesperson for Redeemed Lives deferred comment to a statement the organization made at the conference, which was published on the OSCE website. In the statement, Mario Bergner, director of Redeemed Lives, stresses the importance passing legislation to protect the free speech of Christian academics and clerics to “teach the sexual morality of their faith traditions” so that they can help those with “unwanted sexual desires.”
“Such people include Christians with sexual addictions for whom freedom means living free of internet pornography, Christians with compulsive sexual behaviours for whom freedom is fidelity in marriage, and Christians, like myself, with unwanted same sex attractions for whom freedom is the self emancipation that comes through effective pastoral care or psychological treatment for homosexuality,” Berger said.
Bromley said the organization’s concern about hate crimes against people who identify as “ex-gay” is ironic because the Matthew Shepard Act already protects them.
“It would actually be covered under our current hate crime law because it would still be violence on the basis of sexual orientation,” Bromley said.
But the conference nonetheless provided a forum to discuss international LGBT rights as a human rights issue.
Guest noted progress was made at the conference, although he said more work is needed.
“I think there are moments like that where you feel that you are making headway in getting people to understand that these are issues that governments have to take seriously,” Guest said. “And then, there are other times where it seems to go right past — certainly on some the freedom of association things.”
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
How to cope when a partner gives you the silent treatment
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
Holiday week brings setbacks for Trump-Vance trans agenda
Your guide to D.C.’s queer New Year’s Eve parties
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
